Consistent with this, the levels of CEACAM1 (Fig. 5g) were significantly increased on the immDC and mDC in the treatment-resistant tumors; PD-L1 was increased on both treatment-naive and -resistant tumor groups (Fig. 5i). This evidence concerns the gene CEACAM1 and neoplasm.